相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Lena Katharina Freudenmann et al.
IMMUNOLOGY (2018)
被撤回的出版物: Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma (Retracted article. See vol. 18, pg. 1270, 2019)
Bracha Shraibman et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Concepts in glioma immunotherapy
Michael Platten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
Roy Rampling et al.
CLINICAL CANCER RESEARCH (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
Markus W. Loeffler et al.
JOURNAL OF HEPATOLOGY (2016)
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
Tanner M. Johanns et al.
CANCER DISCOVERY (2016)
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Shelly Kalaora et al.
ONCOTARGET (2016)
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J. A. M. Santegoets et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H. Lawson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days
Eiji Kobayashi et al.
NATURE MEDICINE (2013)
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Valerie Dutoit et al.
BRAIN (2012)
Harmonization of the intracellular cytokine staining assay
Marij J. P. Welters et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Promiscuous survivin peptide induces robust CD4+T-cell responses in the majority of vaccinated cancer patients
Melanie Widenmeyer et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Immune epitope database analysis resource
Yohan Kim et al.
NUCLEIC ACIDS RESEARCH (2012)
Primer3-new capabilities and interfaces
Andreas Untergasser et al.
NUCLEIC ACIDS RESEARCH (2012)
Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A flow cytometry-based assay to assess minute frequencies of CD8+ T cells by their cytolytic function
Jonas Stanke et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers
Sine Reker Hadrup et al.
NATURE METHODS (2009)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
The CIMT-monitoring panel:: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
C. M. Britten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Enhancements and modifications of primer design program Primer3
Triinu Koressaar et al.
BIOINFORMATICS (2007)
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
Cyrille J. Cohen et al.
CANCER RESEARCH (2007)
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells
Sine Reker Hadrup et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes
PT Straten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Generation of peptide-MHC class I complexes through UV-mediated ligand exchange
Boris Rodenko et al.
NATURE PROTOCOLS (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
H Singh-Jasuja et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Cutting edge:: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres
S Walter et al.
JOURNAL OF IMMUNOLOGY (2003)
BLAT - The BLAST-like alignment tool
WJ Kent
GENOME RESEARCH (2002)
分享论文
